PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial

Type de document :
Communication dans un congrès
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. Annals of Oncology, Volume 28, Issue suppl_5, 28 (suppl_5), pp.505P, 2017, Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8–12 September 2017, Madrid, Spain. 〈https://academic.oup.com/annonc/article/28/suppl_5/mdx393.031/4109803/505PFOLFIRINOX-as-induction-treatment-in-rectal〉. 〈10.1093/annonc/mdx393.031〉
Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01632415
Contributeur : Lnc - Université de Bourgogne <>
Soumis le : vendredi 10 novembre 2017 - 10:40:56
Dernière modification le : mercredi 20 juin 2018 - 11:56:11

Lien texte intégral

Identifiants

Collections

Citation

J-B. Bachet, O. Lucidarme, C.B. Levache, E. Maillard, J.L. Raoul, et al.. PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial. the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. Annals of Oncology, Volume 28, Issue suppl_5, 28 (suppl_5), pp.505P, 2017, Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8–12 September 2017, Madrid, Spain. 〈https://academic.oup.com/annonc/article/28/suppl_5/mdx393.031/4109803/505PFOLFIRINOX-as-induction-treatment-in-rectal〉. 〈10.1093/annonc/mdx393.031〉. 〈hal-01632415〉

Partager

Métriques

Consultations de la notice

29